Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer

<div>Recurrence-free survival (RFS) of patients in high and low Ki-67 breast cancer according to progesterone receptor expression status. (a) RFS according to Ki-67 in the low progesterone receptor expression subset (PgR &lt; 20%). (b) RFS according to Ki-67 in the high progesterone receptor expression subset (PgR ≥ 20%).</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer 

Figure 2 | Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer 